Pharma-Bio Serv, Inc. reported revenues of $2.70 million for the three months ended April 30, 2026, an increase from $2.42 million in the same period last year. Net income for the quarter was $232,986, a significant increase from $95,353 in the prior year's quarter. For the six-month period ended April 30, 2026, revenues were $5.00 million, up from $4.89 million in the prior year. Net income for the six-month period was $265,846, compared to $103,889 in the prior year. The company's Puerto Rico consulting segment showed strong performance, while the US consulting segment experienced a decline. Selling, general, and administrative expenses decreased by approximately $0.2 million in both the three-month and six-month periods compared to the prior year, attributed to reduced occupancy expenses and other planned savings. The company had approximately $10.2 million in working capital as of April 30, 2026. The company repurchased 4,300 shares of its common stock during the six-month period ended April 30, 2026.